Author | Lothar M. Kirsch MD

Articles

Infliximab Biosimilars Launch in Europe. (So What?)

February 23, 2015

Two biosimilars for the TNF inhibitor infliximab are now licensed and distributed in Europe. A German rheumatologist wonders what difference the option to prescribe Inflektra and Remsima will make, if any.